References
- Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011;5:CD001750
- Depalo R, Jayakrishan K, Garruti G, et al. GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET). Reprod Biol Endocrinol 2012;10:26
- Detti L, Ambler D, Yelian F, et al. Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes. J Assist Reprod Genet 2008;25:177–81
- Hernandez ER. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 2000;15:1211–16
- Duijkers I, Klipping C, Willemsen W, et al. Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotropin-releasing hormone antagonist (Cetrorelix) in healthy female volunteers. Human Reprod 1998;13:2392–8
- Kolibiankis E, Zikopoulos K, Smitz J, et al. Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization. Fertil Steril 2004;82:223–6
- Al-Inany H, Aboulaghar M, Mansour R, Serour G. Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol. Human Biomed Online 2005;10:567–70
- Tannus S, Weissman A, Boaz M, et al. The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome. Fertil Steril 2013;99:725–30
- Kyrou D, Kolibianakis E, Fatemi H, et al. Is earlier administration of human chorionic gonadotropin (HCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? Fertil Steril 2011;96:1112–15
- Chen Y, Zhang Y, Hu M, et al. Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis. Gynecol Endocrinol 2014;30:431–7
- Tremellen KP, Lane M. Avoidance of weekend oocyte retrieval during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes. Hum Reprod 2010;25:1219–24
- Morley L, Tang T, Yasmin E, et al. Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial. Hum Fertil 2012;15:134–9
- Kolibianakis E, Kalogeropoulou L, Griesinger G, et al. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update 2007;13:445–52
- Bosch E, Labarta E, Crespo J, et al. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril 2011;95:1031–6
- Weinerman R, Mainigi M. Why we should transfer frozen instead of fresh embryos: the translational rationale. Fertil Steril 2014;102:10–18
- Market-Velker B, Zhang L, Bonvissuto A, Mann M. Dual effects of superovulation; loss of maternal and paternal imprinted methylation in a dose-dependent manner. Hum Mol Genet 2010;19:36–51
- Doherty L, Martin J, Kayisli U, et al. Fresh transfer outcome predicts the success of a subsequent frozen transfer utilizing blastocysts of the same cohort. Reprod Biomed Online 2014;28:204–8
- Roque M, Lattes K, Serra S, et al. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril 2013;99:156–62